Extramiana Fabrice, Maison-Blanche Pierre, Tavernier René, Jordaens Luc, Leenhardt Antoine, Coumel Philippe
Hôpital Lariboisière, Service de Cardiologie, 2 rue Ambroise Paré, 75010 Paris, France.
Ann Noninvasive Electrocardiol. 2002 Oct;7(4):379-88. doi: 10.1111/j.1542-474x.2002.tb00189.x.
Although well established on the sinus node, the effects of beta-blockade on ventricular repolarization are still conflicting. The aim of the study was to investigate the effects of a chronic beta-blockade on sinus node and repolarization parameters and their relationship.
Sixteen healthy volunteers (10 males, mean age: 40 +/- 6.7 years) were randomized to placebo or atenolol (100 mg). After 7 days, subjects were crossed over. Heart rate (HR) and HRV indices were calculated from long-term ECG recordings separately during the day and at night, together with ventricular repolarization parameters (QT interval duration and QT rate-dependence).
Mean R-R intervals were significantly and consistently increased after atenolol (Day: 916 +/- 103 ms vs. 712 +/- 89 ms, and Night: 1149 +/- 93 vs. 996 +/- 125 ms). HRV changes under atenolol were also consistent, with a significant decrease in sympathovagal ratio. In contrast, atenolol only lowered diurnal QT rate-dependence (0.123 +/- 0.032 vs. 0.190 +/- 0.065 on placebo, P < 0.001), but not the nocturnal pattern. After multivariate analysis QT rate-dependence changes induced by atenolol were correlated with pretreatment QT/RR relation (r = 0.65, P < 0.01) but not with any HR or HRV parameters.
In healthy subjects, repolarization changes following chronic beta-blockade cannot be predicted by HR or HRV changes, but are dependent on pretreatment rate-dependence.
虽然β受体阻滞剂对窦房结的作用已得到充分证实,但其对心室复极的影响仍存在争议。本研究旨在探讨慢性β受体阻滞剂对窦房结和复极参数的影响及其关系。
16名健康志愿者(10名男性,平均年龄:40±6.7岁)被随机分为安慰剂组或阿替洛尔组(100毫克)。7天后,受试者进行交叉。分别在白天和晚上从长期心电图记录中计算心率(HR)和HRV指标,以及心室复极参数(QT间期持续时间和QT频率依赖性)。
服用阿替洛尔后,平均R-R间期显著且持续增加(白天:916±103毫秒对712±89毫秒,晚上:1149±93对996±125毫秒)。阿替洛尔治疗下的HRV变化也一致,交感迷走神经比值显著降低。相比之下,阿替洛尔仅降低了日间QT频率依赖性(安慰剂组为0.190±0.065,阿替洛尔组为0.123±0.032,P<0.001),但对夜间模式无影响。多因素分析后,阿替洛尔引起的QT频率依赖性变化与治疗前QT/RR关系相关(r=0.65,P<0.01),但与任何HR或HRV参数无关。
在健康受试者中,慢性β受体阻滞剂后的复极变化不能通过HR或HRV变化预测,而是取决于治疗前的频率依赖性。